Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotixin glucopyranoside derivatives.

× No keyword cloud information.

27 in total

Review 1. Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors: Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

Review 2. The podophyllotoxin derivatives VP16-213 and VM26.

Authors: B F Issell
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

Review 3. VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.

Authors: J D Loike
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

4. Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide.

Authors: K H Pflüger; L Schmidt; M Merkel; H Jungclas; K Havemann
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

5. Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.

Authors: P Canal; R Bugat; C Michel; H Roche; G Soula; P F Combes
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

6. Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.

Authors: R T Dorr; D S Alberts
Journal: Invest New Drugs Date: 1983 Impact factor: 3.850

Review 7. Pharmacokinetics of anticancer drugs in children.

Authors: W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal: Clin Pharmacokinet Date: 1987-03 Impact factor: 6.447

8. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.

Authors: B F Issell; C Tihon; M E Curry
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

9. Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.

Authors: W E Evans; J A Sinkule; W R Crom; L Dow; A T Look; G Rivera
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

10. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?

Authors: L M Allen; F Tejada; A D Okonmah; S Nordqvist
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333